p53 Expression and cell proliferation in squamous cell carcinomas of the head and neck

Cancer

Volumn 75, Issue 1, 1995, Pages 87-93

  Nylander, Karin ^a   Stenling, Roger ^a   Gustafsson, Hans ^a   Zackrisson, Björn ^a   Roos, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

cell proliferation; head and neck; immunohistochemistry; iododeoxyuridine labeling; p53; proliferating cell nuclear antigen; squamous cell carcinoma

Indexed keywords

CYCLINE; EPITOPE; IDOXURIDINE; MONOCLONAL ANTIBODY; PROTEIN P53;

ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; GENE EXPRESSION; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SUPPORT, NON-U.S. GOV'T;

EID: 0028832048     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950101)75:1<87::AID-CNCR2820750115>3.0.CO;2-V     Document Type: Article

References (38)

1. Frequent p53 mutations in head and neck cancer
2. p53: oncogene or anti‐oncogene?
3. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form
4. p53 gene alterations in human prostate carcinoma
5. Overexpression of p53 is a late event in the development of malignant melanoma
6. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy
7. p53 alterations in human squamous cell carcinomas and carcinoma cell lines
8. Expression of mutated p53 occurs in rumor‐distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors
9. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor‐suppressor genes
10. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
11. Expression of p53 in premalignant and malignant squamous epithelium
12. Expression of the tumor suppressor gene p53 in oral cancer
13. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
14. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation
15. Expression of p53 in human esophageal carcinoma: An immunohistochemical study with correlation to proliferating cell; nuclear antigen expression
16. Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis
17. Prognostic significance of p53 mutations and 3p deletions in primary resected non‐small cell lung cancer
18. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor
19. Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression
20. Analysis of p53 expression in human tumors: an antibody raised against human p53 expressed in Escherichia coli
21. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53
22. Monoclonal antibody to 5‐bromo‐ and 5‐iododeoxyuridine: a new reagent for detection of DNA replication
23. Detection of p53 overexpression in routinely paraffin‐embedded tissue of human carcinomas using a novel target unmasking fluid
24. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
25. Accumulation of wild type p53 protein in human astrocytomas
26. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas
27. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas
28. p53, guardian of the genome
29. Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells
30. Cyclin (PCNA, auxiliary protein of DNA polymerase ) is a central component of the pathway(s) leading to DNA replication and cell division
31. Cell kinetics of head and neck squamous cell carcinomas, prognostic implications
32. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors
33. p53 over‐expression is an early event in the development of human squamous‐cell carcinoma of the larynx: genetic and prognostic implications
34. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma
35. Normal and malignant growth control by p53
36. A codon 248 p53 mutation retains tumor suppressor function as shown by enhancement of tumor growth by antisensep53